NO872825D0 - Fremgangsmaate for fremstilling av antibakterielt aktive cefalosporinderivater. - Google Patents

Fremgangsmaate for fremstilling av antibakterielt aktive cefalosporinderivater.

Info

Publication number
NO872825D0
NO872825D0 NO872825A NO872825A NO872825D0 NO 872825 D0 NO872825 D0 NO 872825D0 NO 872825 A NO872825 A NO 872825A NO 872825 A NO872825 A NO 872825A NO 872825 D0 NO872825 D0 NO 872825D0
Authority
NO
Norway
Prior art keywords
antibacteryly
procedure
active
preparation
cephalosporine derivatives
Prior art date
Application number
NO872825A
Other languages
English (en)
Other versions
NO171726B (no
NO872825L (no
NO171726C (no
Inventor
Ving Jick Lee
William Vincent Curran
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO872825D0 publication Critical patent/NO872825D0/no
Publication of NO872825L publication Critical patent/NO872825L/no
Publication of NO171726B publication Critical patent/NO171726B/no
Publication of NO171726C publication Critical patent/NO171726C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO872825A 1986-07-08 1987-07-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3((1,2,3-tiadiazol-4-yl)tiometyl)-8-okso-5-tia-1-azabicyklo(4.2.0)okt-2-en-2-karboksylsyrederivater NO171726C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88299686A 1986-07-08 1986-07-08

Publications (4)

Publication Number Publication Date
NO872825D0 true NO872825D0 (no) 1987-07-07
NO872825L NO872825L (no) 1988-01-11
NO171726B NO171726B (no) 1993-01-18
NO171726C NO171726C (no) 1993-04-28

Family

ID=25381778

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872825A NO171726C (no) 1986-07-08 1987-07-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3((1,2,3-tiadiazol-4-yl)tiometyl)-8-okso-5-tia-1-azabicyklo(4.2.0)okt-2-en-2-karboksylsyrederivater

Country Status (14)

Country Link
EP (1) EP0252473A3 (no)
JP (1) JPH0813820B2 (no)
KR (1) KR950008320B1 (no)
AU (1) AU599676B2 (no)
CA (1) CA1284147C (no)
DK (1) DK349687A (no)
FI (1) FI88042C (no)
HU (1) HU198070B (no)
IL (1) IL83119A (no)
NO (1) NO171726C (no)
NZ (1) NZ220995A (no)
PH (1) PH24324A (no)
PT (1) PT85276B (no)
ZA (1) ZA874941B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803280A (en) * 1986-07-08 1989-02-07 American Cyanamid Company Substituted 1,2,3-thia-diazole-4-thiolates
GB2517979A (en) * 2013-09-06 2015-03-11 Taylor Kerr Couplings Ltd Pipe coupling with dynamic axial restraint system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399132A (en) * 1980-08-11 1983-08-16 American Cyanamid Company 7-Beta-[alpha-syn-methoxyimino-alpha-(2-aminothiazol-4-yl)-acetamido]-3-[(1,2,3-thiadiazol-5-ylthio)methyl]-3-cephem-4-carboxylic acid and C1 -C6 alkyl derivatives thereof
US4914091A (en) * 1984-04-02 1990-04-03 American Cyanamid Company Esters of cephalosporin derivitives
EP0168177A3 (en) * 1984-06-28 1987-04-01 Pfizer Limited Cephalosporin antibiotics

Also Published As

Publication number Publication date
KR950008320B1 (ko) 1995-07-27
HU198070B (en) 1989-07-28
JPH0813820B2 (ja) 1996-02-14
HUT45070A (en) 1988-05-30
NO171726B (no) 1993-01-18
PT85276A (en) 1987-08-01
FI872999A0 (fi) 1987-07-07
FI872999A (fi) 1988-01-09
EP0252473A3 (en) 1989-07-05
AU599676B2 (en) 1990-07-26
NZ220995A (en) 1989-10-27
KR890002181A (ko) 1989-04-08
NO872825L (no) 1988-01-11
ZA874941B (en) 1988-02-24
IL83119A (en) 1993-04-04
DK349687A (da) 1988-01-09
FI88042C (fi) 1993-03-25
JPS6388188A (ja) 1988-04-19
IL83119A0 (en) 1987-12-31
AU7531187A (en) 1988-01-14
CA1284147C (en) 1991-05-14
EP0252473A2 (en) 1988-01-13
PH24324A (en) 1990-05-29
DK349687D0 (da) 1987-07-07
FI88042B (fi) 1992-12-15
PT85276B (pt) 1990-03-30
NO171726C (no) 1993-04-28

Similar Documents

Publication Publication Date Title
NO870579D0 (no) Fremgangsmaate for fremstilling av indolizin-derivater.
NO871266D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO871267L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO862661L (no) Fremgangsmaate for fremstilling av n-aralkylpiperidinmethanolderivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO870075L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO874032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO871588D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO874467D0 (no) Fremgangsmaate for fremstilling av 3-pyrrolidinoler.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO880910D0 (no) Fremgangsmaate for fremstilling av chromonderivater.
NO874268D0 (no) Fremgangsmaate for fremstilling av n-substituerte piperazinoner.
NO844036L (no) Fremgangsmaate for fremstilling av cefalosporinderivater.
NO873514L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
NO884900D0 (no) Fremgangsmaate for fremstilling av ginkolid-derivater.
NO873400D0 (no) Fremgangsmaate for fremstilling av sulfidfri alkalivaeske.
NO874199D0 (no) Fremgangsmaate for fremstilling av imidazo-pyridinonderivater.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO872690D0 (no) Fremgangsmaate for fremstilling av mercaptoacylprolin.
NO872825D0 (no) Fremgangsmaate for fremstilling av antibakterielt aktive cefalosporinderivater.
NO883398D0 (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO874698D0 (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivater.
NO884100L (no) Fremgangsmaate for fremstilling av halogentiazolderivater.
NO853525L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
NO873019D0 (no) Fremgangsmaate for fremstilling av tetrahydrobenzotiazolkinolin-derivater.